Rifampin description

Revision as of 22:06, 5 January 2014 by Chetan Lokhande (talk | contribs) (Created page with "__NOTOC__ {{Rifampin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFA...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Rifampin
FDA Package Insert (Rifadin®)
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]



[1]


References

  1. ↑ "RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC]".

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Rifampin_description&oldid=925001"